Dow Jones

40 211,72

0,00%

DAX

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

Accueil
Investir
Actions
Italie
BIT
Abitare In Spa (ABT)
Abitare In Spa (ABT) Actualités

ABT

Abitare In (ABT)

Abitare In Spa

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:BIT:ABT

<< Précédent 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
21/01/2009	20h09	Dow Jones News	CORRECT: Abbott Stent Sales $410 Million, Not $257 Million	NYSE:ABT	Abbott Laboratories
21/01/2009	17h43	Dow Jones News	UPDATE: Abbott 4Q Net Up 28% On Xience, Humira Sales Growth	NYSE:ABT	Abbott Laboratories
21/01/2009	15h56	Dow Jones News	CORRECT: Abbott 4Q Stent Sales Rose 125%, Not 36%	NYSE:ABT	Abbott Laboratories
21/01/2009	14h43	Dow Jones News	Abbott Labs 4Q Net Up 28%, Helped By Xience Stent, Humira Salesx	NYSE:ABT	Abbott Laboratories
20/01/2009	18h12	Dow Jones News	2nd UPDATE: J&J 4Q Net Up 14%; Gives Weaker '09 View	NYSE:ABT	Abbott Laboratories
20/01/2009	16h53	Dow Jones News	UPDATE: J&J 4Q Net Up 14%; Gives Weaker '09 View	NYSE:ABT	Abbott Laboratories
19/01/2009	23h07	PR Newswire (US)	Abbott Nutrition Announces Voluntary Recall of ZonePerfect(R) Chocolate Peanut Butter Bars, ZonePerfect(R) Peanut Toffee Bars an	NYSE:ABT
19/01/2009	15h00	PR Newswire (US)	Abbott Receives FDA CLIA Waiver for Use of Five Additional Cartridges on the i-STAT Handheld Blood Analyzer	NYSE:ABT
16/01/2009	21h05	Dow Jones News	US EQUITIES WEEK AHEAD: Quarterly Data, Inauguration Ahead	NYSE:ABT	Abbott Laboratories
13/01/2009	00h15	Dow Jones News	Big M&A Likely To Remain Rare Despite Monday's Pricey Deal	NYSE:ABT	Abbott Laboratories
12/01/2009	22h17	Dow Jones News	Abbott Deal Shows There's Room For Easy Healthcare M&A	NYSE:ABT	Abbott Laboratories
12/01/2009	22h06	Dow Jones News	Abbott Standing Pat Now, But Vision Deal Could Yield More	NYSE:ABT	Abbott Laboratories
12/01/2009	18h13	Dow Jones News	2nd UPDATE: Abbott To Buy Advanced Medical For $1.36 Billion	NYSE:ABT	Abbott Laboratories
12/01/2009	17h07	Dow Jones News	UPDATE: Abbott Labs To Buy Advanced Medical For $1.36 Billion	NYSE:ABT	Abbott Laboratories
12/01/2009	15h07	Dow Jones News	Abbott Labs To Buy Advanced Medical For $1.36 Billion	NYSE:ABT	Abbott Laboratories
12/01/2009	14h04	PR Newswire (US)	Abbott Announces Earnings Guidance for 2009	NYSE:ABT
05/01/2009	20h15	Dow Jones News	Panel Issues New Criteria For Treatment Of Heart Blockage	NYSE:ABT	Abbott Laboratories
18/12/2008	15h13	PR Newswire (US)	Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2008 Earnings	NYSE:ABT
16/12/2008	15h17	PR Newswire (US)	Abbott to Present at J.P. Morgan Healthcare Conference	NYSE:ABT
05/11/2008	18h54	PR Newswire (US)	Super Jake Foundation Hosts 4th Annual 'Heroes Bash' on Nov. 8 to Benefit Pediatric Cancer Research	NYSE:ABT
20/10/2008	22h35	PR Newswire (US)	Abbott Receives Complete Response Letter From FDA for Controlled-Release Hydrocodone With Acetaminophen	NYSE:ABT
11/09/2008	20h26	PR Newswire (US)	American Diabetes Association Announces New Latino Diabetes Toolkit	NYSE:ABT
29/08/2008	21h34	PR Newswire (US)	Abbott Fund to Build First Pediatric HIV/AIDS Clinic in Tanzania	NYSE:ABT
30/07/2008	19h29	PR Newswire (US)	Abbott Donates Diagnostic Instruments As Part of the 'Labs Are Vital(TM)' Initiative	NYSE:ABT
30/07/2008	15h00	PR Newswire (US)	Precise Low-Dose Drug Monitoring Essential for Long-Term Kidney Transplant Success	NYSE:ABT
30/07/2008	02h00	PR Newswire (US)	Novel Diagnostic Marker for Acute Kidney Injury Previewed at Abbott-Sponsored Scientific Workshop	NYSE:ABT
09/07/2008	20h30	PR Newswire (US)	Abbott Begins Post-Approval Study of XIENCE V(TM) Drug Eluting Stent	NYSE:ABT
02/07/2008	23h19	PR Newswire (US)	FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent	NYSE:ABT
24/06/2008	15h32	PR Newswire (US)	Abbott and Partnership for a Drug-Free America Launch 'Not In My House' to Help Parents Secure Their Homes from Teen Prescriptio	NYSE:ABT
13/06/2008	08h00	PR Newswire (US)	New Long-Term HUMIRA(R) (adalimumab) Data Show Up to Seven-Year Efficacy with Combination Treatment for Rheumatoid Arthritis	NYSE:ABT